U.S. stock markets experienced a downturn on Thursday, with the Nasdaq Composite shedding over 170 points and ending the day at 19,338.29.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story UnitedHealth CEO blames drug companies for high costsIn his first public remarks since the murder of

U.S. stock indexes drifted lower following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group and other big companies

In its first results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group reported Thursday weaker-than-expected fourth-quarter revenue, prompting its shares to fall in early morning trading despite quarterly profit beating projections.

Thursday's trading session has presented significant movements among stocks, particularly within the mega-cap and large-cap segments. Market participants have witnessed notable declines in heavyweight stocks like UnitedHealth Group (UNH) and Tesla Motors (NASDAQ:TSLA),

U.S. stocks erased a modest early gain, with the S&P 500 struggling to tally a fourth-straight advance. The index was marginally lower in recent trading, although it was outperforming both the Nasdaq Composite and the Dow.

U.S. stock indexes drifted lower Thursday following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group and other big companies. More stocks rose within the index than fell, but drops for some influential stocks like Tesla outweighed them.

Shares are mostly lower in Asia after China reported that its economy grew at a 5% annual pace last year, hitting the government's target but slowing from the year before

Shares were mostly lower in Asia on Friday after China reported that its economy grew at a 5% annual pace last year, hitting the government’s target but slowing from the year before.

NEW YORK — U.S. stock indexes drifted lower Thursday following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group and other big companies.

Here are seven figures on the hack's financial toll in 2024, according to the healthcare conglomerate's year-end earnings report: